We discovered notable variations in CXCR5 DNA methylation levels across patients with RA and SLE compared with HC, indicating that CXCR5 methylation status may contribute to the pathophysiology of these autoimmune disorders. Here, CXCR5 is linked to systemic lupus erythematosus.